Startups
AI drug development startup Pathos AI closes $237M investment
AI drug development startup Pathos AI raises $237 million in Series E funding at a $3 billion valuation, led by Bristol Myers Squibb.
Stories tagged by our AI curator.
AI drug development startup Pathos AI raises $237 million in Series E funding at a $3 billion valuation, led by Bristol Myers Squibb.
Legal AI startup Legora raised $550 million in Series E funding at an $8.8 billion valuation.
Legora, a Swedish legal tech platform, raised €489 million ($550 million) in Series E funding at an €7.8 billion valuation led by Atreides Management.
Financial planning and reporting software startup Pigment has raised $250 million in a Series E funding round led by Scaleup Europe Fund.
French enterprise software startup Pigment raised $250M at a $2.3bn valuation in a Series E round led by the EU's Scaleup Europe Fund, with backing from existing investors and Nvidia.